The University of Chicago Header Logo

Jessica Donington

Concepts (421)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Non-Small-Cell Lung
58
2024
1113
13.870
Why?
Lung Neoplasms
83
2024
2344
12.980
Why?
Pneumonectomy
25
2024
206
6.470
Why?
Neoplasm Staging
41
2024
1989
3.650
Why?
Thoracic Surgery
8
2022
43
3.130
Why?
Neoadjuvant Therapy
9
2024
366
2.290
Why?
Surgeons
6
2022
247
2.020
Why?
Osteopontin
6
2013
47
1.930
Why?
Thoracic Surgical Procedures
5
2024
55
1.740
Why?
Radiosurgery
9
2021
280
1.700
Why?
Physicians, Women
5
2022
56
1.560
Why?
Humans
138
2024
88852
1.530
Why?
Specialties, Surgical
2
2021
65
1.410
Why?
Neoplasm Recurrence, Local
12
2023
1354
1.370
Why?
Early Detection of Cancer
5
2024
411
1.360
Why?
Thoracic Surgery, Video-Assisted
6
2022
30
1.340
Why?
Mesothelioma
14
2023
322
1.260
Why?
Adenocarcinoma
11
2016
1194
1.240
Why?
Pleural Neoplasms
11
2016
197
1.140
Why?
Small Cell Lung Carcinoma
4
2023
103
1.090
Why?
Esophagectomy
5
2009
92
1.060
Why?
Disease Management
3
2019
328
0.870
Why?
Chemotherapy, Adjuvant
6
2022
485
0.850
Why?
Catheter Ablation
6
2015
252
0.840
Why?
Thymectomy
1
2022
31
0.840
Why?
Jehovah's Witnesses
1
2022
20
0.840
Why?
Tomography, X-Ray Computed
11
2020
2649
0.830
Why?
Immunotherapy
6
2023
664
0.820
Why?
Radium
4
2023
7
0.800
Why?
Myasthenia Gravis
1
2022
83
0.800
Why?
Biomarkers, Tumor
5
2021
1532
0.770
Why?
Symptom Assessment
1
2020
66
0.720
Why?
United States
18
2024
6931
0.720
Why?
Treatment Outcome
15
2024
8178
0.720
Why?
Societies, Medical
4
2024
567
0.710
Why?
Antibody Formation
1
2020
171
0.710
Why?
Esophageal Neoplasms
4
2009
332
0.700
Why?
Antibodies, Viral
2
2021
308
0.690
Why?
Combined Modality Therapy
11
2022
1708
0.690
Why?
Female
50
2024
45899
0.680
Why?
Surgical Flaps
3
2017
249
0.670
Why?
Aged
32
2024
19019
0.660
Why?
Mass Screening
3
2022
631
0.660
Why?
Male
45
2024
42135
0.660
Why?
Carcinoma, Squamous Cell
5
2016
1095
0.640
Why?
Robotic Surgical Procedures
2
2022
300
0.630
Why?
SEER Program
4
2024
197
0.620
Why?
Middle Aged
36
2024
25787
0.620
Why?
Neoplasms, Second Primary
5
2016
259
0.610
Why?
Retrospective Studies
16
2024
8963
0.570
Why?
Probability
1
2017
353
0.560
Why?
Salvage Therapy
2
2017
235
0.560
Why?
Skin Ulcer
1
2016
25
0.560
Why?
Hyaluronan Receptors
2
2013
38
0.530
Why?
Frozen Sections
1
2015
49
0.520
Why?
Prognosis
16
2021
3757
0.510
Why?
Skin Transplantation
1
2016
183
0.510
Why?
Aged, 80 and over
17
2024
6758
0.500
Why?
Monitoring, Intraoperative
1
2015
110
0.500
Why?
Esophagus
2
2006
106
0.500
Why?
Fluorodeoxyglucose F18
3
2012
142
0.470
Why?
Pancoast Syndrome
1
2013
2
0.460
Why?
Survival Rate
10
2024
1881
0.460
Why?
Radiopharmaceuticals
3
2012
193
0.460
Why?
Fas Ligand Protein
1
2013
49
0.440
Why?
Adult
28
2024
26439
0.430
Why?
Positron-Emission Tomography
5
2013
336
0.420
Why?
Fluorine Radioisotopes
1
2012
25
0.400
Why?
Radiation Injuries
2
2010
160
0.400
Why?
Cyclooxygenase 2
1
2012
99
0.400
Why?
Skin Neoplasms
1
2016
578
0.390
Why?
Multimodal Imaging
1
2012
111
0.380
Why?
Neurosurgical Procedures
1
2013
232
0.380
Why?
Bronchogenic Cyst
1
2010
5
0.380
Why?
Thoracic Diseases
1
2010
27
0.370
Why?
Soft Tissue Infections
1
2010
26
0.370
Why?
Thoracic Wall
1
2010
25
0.370
Why?
Clinical Trials as Topic
4
2020
1146
0.360
Why?
Risk Assessment
7
2022
2286
0.350
Why?
Cost-Benefit Analysis
2
2024
461
0.340
Why?
Survival Analysis
4
2019
1533
0.340
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2024
2550
0.340
Why?
Radiotherapy, Adjuvant
3
2022
295
0.340
Why?
Simulation Training
2
2021
96
0.340
Why?
Education, Medical, Graduate
3
2020
390
0.340
Why?
Lung Transplantation
2
2024
282
0.330
Why?
Health Status Disparities
1
2011
186
0.320
Why?
Perfusion
3
2024
234
0.310
Why?
Neoplasm Proteins
1
2012
540
0.310
Why?
Consensus
4
2024
355
0.290
Why?
Dumping Syndrome
1
2006
5
0.270
Why?
Gastric Emptying
1
2006
25
0.270
Why?
Healthcare Disparities
1
2011
405
0.270
Why?
Protein Kinase Inhibitors
2
2022
602
0.260
Why?
Antineoplastic Agents
5
2020
2410
0.260
Why?
Stomach
1
2006
111
0.250
Why?
Esophageal Diseases
1
2005
27
0.250
Why?
Patient Selection
3
2020
681
0.250
Why?
Pneumonia, Viral
2
2020
319
0.250
Why?
Coronavirus Infections
2
2020
304
0.250
Why?
Transcription Factors
1
2013
1650
0.250
Why?
Wounds, Nonpenetrating
1
2006
102
0.250
Why?
Patient Care Management
2
2020
30
0.250
Why?
Lung
5
2024
1257
0.240
Why?
Intubation, Intratracheal
1
2006
147
0.240
Why?
Deglutition Disorders
1
2006
119
0.240
Why?
Computer Simulation
3
2021
1096
0.240
Why?
Chemoradiotherapy
3
2024
309
0.240
Why?
General Surgery
1
2007
235
0.240
Why?
Risk Factors
5
2022
5448
0.240
Why?
Follow-Up Studies
5
2024
3649
0.230
Why?
Gastroesophageal Reflux
1
2006
122
0.230
Why?
Postoperative Complications
4
2024
2273
0.230
Why?
Smoking
2
2024
620
0.220
Why?
Thymoma
1
2023
30
0.220
Why?
Hamartoma
1
2003
34
0.220
Why?
Antibodies, Neutralizing
2
2021
119
0.220
Why?
Negative-Pressure Wound Therapy
2
2014
10
0.220
Why?
Thymus Neoplasms
1
2023
43
0.220
Why?
Lymphatic Metastasis
4
2010
502
0.220
Why?
Medical Oncology
1
2007
379
0.210
Why?
Radiotherapy, Conformal
1
2023
84
0.210
Why?
Frailty
1
2024
76
0.210
Why?
Carcinoma, Bronchogenic
1
2002
30
0.210
Why?
Chylothorax
1
2022
9
0.210
Why?
Chylous Ascites
1
2022
9
0.210
Why?
Time Factors
4
2023
5313
0.200
Why?
Health Care Costs
1
2023
235
0.200
Why?
Neoplasm Metastasis
3
2019
1107
0.200
Why?
ErbB Receptors
2
2022
500
0.190
Why?
Steroids
1
2022
174
0.190
Why?
Loss of Function Mutation
1
2021
46
0.190
Why?
Funnel Chest
1
2021
8
0.190
Why?
Pneumothorax
2
2020
53
0.190
Why?
Lung Diseases
1
2003
269
0.190
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2021
112
0.190
Why?
Cohort Studies
6
2024
2855
0.190
Why?
Spike Glycoprotein, Coronavirus
1
2021
43
0.190
Why?
Immunization, Passive
1
2020
71
0.190
Why?
Betacoronavirus
2
2020
261
0.180
Why?
Critical Pathways
1
2020
37
0.180
Why?
Pandemics
3
2021
770
0.180
Why?
Case-Control Studies
4
2013
1849
0.170
Why?
Sexual Harassment
1
2019
9
0.170
Why?
Career Choice
1
2021
148
0.170
Why?
Clinical Decision-Making
2
2019
279
0.170
Why?
Protein Isoforms
2
2010
273
0.170
Why?
Randomized Controlled Trials as Topic
2
2020
832
0.160
Why?
Drainage
1
2020
159
0.160
Why?
Nontuberculous Mycobacteria
1
2018
10
0.160
Why?
Sexism
1
2019
53
0.160
Why?
Mycobacterium Infections, Nontuberculous
1
2018
27
0.160
Why?
Immunoglobulin G
1
2020
463
0.160
Why?
Diagnosis, Differential
4
2013
1590
0.150
Why?
Thoracotomy
1
2018
63
0.150
Why?
Periodicals as Topic
1
2020
168
0.150
Why?
Respiratory System
1
2018
116
0.150
Why?
Drug Resistance, Neoplasm
1
2021
615
0.150
Why?
Safety-net Providers
1
2018
37
0.150
Why?
Wound Closure Techniques
1
2017
15
0.150
Why?
Consolidation Chemotherapy
1
2017
23
0.150
Why?
Thoracic Neoplasms
1
2017
64
0.140
Why?
Evidence-Based Medicine
2
2017
430
0.140
Why?
Prosthesis-Related Infections
1
2017
60
0.140
Why?
Lymph Nodes
2
2011
548
0.140
Why?
Meta-Analysis as Topic
4
2016
86
0.130
Why?
Cell Proliferation
2
2013
1649
0.130
Why?
Asbestos
2
2012
22
0.130
Why?
National Cancer Institute (U.S.)
1
2015
73
0.130
Why?
Defibrillators, Implantable
1
2017
142
0.130
Why?
Forecasting
1
2016
305
0.130
Why?
Apoptosis
2
2013
1715
0.130
Why?
Biopsy
2
2016
1180
0.130
Why?
Surgical Wound Infection
1
2017
201
0.120
Why?
Subcutaneous Emphysema
1
2014
7
0.120
Why?
Photochemotherapy
1
1995
100
0.120
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2013
887
0.120
Why?
Liver Transplantation
1
2022
1175
0.120
Why?
Simian virus 40
4
1998
35
0.120
Why?
Area Under Curve
2
2012
337
0.120
Why?
Prospective Studies
6
2023
4258
0.120
Why?
Radiography
2
2014
809
0.120
Why?
Receptor, EphB2
1
2013
3
0.110
Why?
Neoplasm Invasiveness
2
2013
575
0.110
Why?
Peritoneum
1
2013
57
0.110
Why?
Snail Family Transcription Factors
1
2013
46
0.110
Why?
Neoplasm, Residual
2
2019
181
0.110
Why?
Operative Time
1
2013
141
0.110
Why?
Microbiota
1
2018
398
0.110
Why?
Clinical Protocols
1
2013
157
0.110
Why?
Surveys and Questionnaires
1
2021
2607
0.110
Why?
Blotting, Western
2
2013
794
0.110
Why?
Organ Preservation
2
2024
105
0.110
Why?
ROC Curve
2
2012
778
0.110
Why?
Epithelium
1
2013
325
0.100
Why?
Time-to-Treatment
1
2013
112
0.100
Why?
Pain Management
1
2013
137
0.100
Why?
Extracellular Matrix Proteins
1
2012
127
0.100
Why?
Cytokines
3
2022
801
0.100
Why?
Clinical Trials, Phase III as Topic
2
2007
172
0.100
Why?
Solitary Pulmonary Nodule
1
2013
139
0.100
Why?
Biomarkers
2
2016
1753
0.100
Why?
Job Satisfaction
1
2012
76
0.100
Why?
Occupational Exposure
1
2012
87
0.100
Why?
Young Adult
5
2021
6271
0.100
Why?
Palliative Care
1
2013
263
0.100
Why?
Radiotherapy, Computer-Assisted
1
2011
25
0.100
Why?
Carcinoma, Large Cell
1
2011
39
0.100
Why?
Sternoclavicular Joint
1
2010
2
0.090
Why?
Pulmonary Surgical Procedures
1
2010
8
0.090
Why?
Colony-Forming Units Assay
1
2010
40
0.090
Why?
Antibodies, Monoclonal
1
2017
1399
0.090
Why?
Cranial Irradiation
2
2020
40
0.090
Why?
Ribonucleases
1
2011
93
0.090
Why?
Cell Movement
2
2013
783
0.090
Why?
Debridement
1
2010
57
0.090
Why?
Oligonucleotide Array Sequence Analysis
2
2010
695
0.090
Why?
Computer-Assisted Instruction
1
2011
44
0.090
Why?
Models, Anatomic
1
2011
91
0.090
Why?
Functional Laterality
1
2011
200
0.090
Why?
Tumor Cells, Cultured
3
2009
1057
0.090
Why?
Mutation
1
2022
4121
0.090
Why?
Models, Cardiovascular
1
2011
104
0.090
Why?
Cell Line, Tumor
3
2011
2549
0.090
Why?
Joint Diseases
1
2010
48
0.090
Why?
Tumor Burden
2
2011
308
0.090
Why?
Necrosis
1
2010
209
0.090
Why?
Epithelial-Mesenchymal Transition
1
2010
96
0.090
Why?
Tracheal Neoplasms
1
2009
8
0.090
Why?
Internship and Residency
1
2019
1040
0.090
Why?
Pain, Postoperative
1
2012
251
0.090
Why?
Glomus Tumor
1
2009
9
0.090
Why?
Chest Pain
1
2009
42
0.080
Why?
Sarcoidosis
1
2010
72
0.080
Why?
Cell Adhesion
1
2010
425
0.080
Why?
Opioid-Related Disorders
1
2012
183
0.080
Why?
Endosonography
1
2010
98
0.080
Why?
Tuberculosis
1
2010
121
0.080
Why?
Minimally Invasive Surgical Procedures
1
2011
250
0.080
Why?
Enzyme-Linked Immunosorbent Assay
1
2010
374
0.080
Why?
Mediastinal Neoplasms
2
2005
47
0.080
Why?
RNA, Messenger
2
2013
2011
0.080
Why?
MicroRNAs
2
2011
550
0.080
Why?
Length of Stay
2
2020
732
0.080
Why?
Wound Healing
1
2010
359
0.080
Why?
Microwaves
1
2008
36
0.080
Why?
Radiation Oncologists
2
2018
14
0.080
Why?
Chest Tubes
2
2020
23
0.070
Why?
Analgesics, Opioid
1
2012
441
0.070
Why?
Vascular Endothelial Growth Factor A
1
2009
420
0.070
Why?
NF-kappa B
1
2011
465
0.070
Why?
DNA, Viral
2
1998
261
0.070
Why?
Sex Factors
1
2011
1062
0.070
Why?
Receptor, IGF Type 1
2
1998
45
0.070
Why?
Neovascularization, Pathologic
1
2009
363
0.070
Why?
Gene Expression Profiling
2
2010
1428
0.070
Why?
Diagnostic Imaging
1
2011
478
0.070
Why?
Pulmonary Ventilation
1
2006
33
0.070
Why?
Disease-Free Survival
2
2011
1213
0.070
Why?
Sialoglycoproteins
1
2006
31
0.070
Why?
Cognition
1
2011
579
0.070
Why?
Carbonic Anhydrases
1
2006
15
0.070
Why?
Sex Distribution
1
2006
171
0.070
Why?
Mediastinoscopy
1
2005
5
0.070
Why?
Thoracic Injuries
1
2006
35
0.070
Why?
History, 21st Century
2
2017
180
0.070
Why?
California
1
2006
143
0.070
Why?
Hemangioendothelioma, Epithelioid
1
2005
9
0.060
Why?
Peritoneal Neoplasms
2
1998
184
0.060
Why?
Radiotherapy Dosage
1
2006
470
0.060
Why?
Esophagoplasty
1
2005
10
0.060
Why?
Anesthetics
1
2005
53
0.060
Why?
Blood Loss, Surgical
1
2005
115
0.060
Why?
Risk
1
2006
657
0.060
Why?
Eligibility Determination
1
2024
36
0.060
Why?
Antigens, Neoplasm
1
2006
332
0.060
Why?
Frail Elderly
1
2024
81
0.060
Why?
Adolescent
3
2021
9201
0.060
Why?
Incidence
2
2022
1591
0.060
Why?
Postoperative Care
1
2024
228
0.050
Why?
Elective Surgical Procedures
1
2024
126
0.050
Why?
DNA Helicases
1
2023
84
0.050
Why?
Preoperative Care
1
2005
395
0.050
Why?
Proto-Oncogene Proteins c-ret
1
2022
23
0.050
Why?
Work-Life Balance
1
2022
6
0.050
Why?
Adaptor Proteins, Signal Transducing
1
2023
311
0.050
Why?
Asthma
1
2009
975
0.050
Why?
Transfection
3
2011
911
0.050
Why?
Leukocytes
1
2022
204
0.050
Why?
Hospital Mortality
1
2003
386
0.050
Why?
Cross Reactions
1
2021
109
0.050
Why?
Oxygen
1
2006
742
0.050
Why?
Clinical Competence
2
2020
780
0.050
Why?
Antigens, Viral
1
2021
145
0.050
Why?
Practice Guidelines as Topic
2
2018
1040
0.050
Why?
Immunity, Humoral
1
2021
66
0.050
Why?
Epitopes
1
2021
255
0.040
Why?
Bioethics
1
2020
35
0.040
Why?
Risk Management
1
2020
42
0.040
Why?
Etoposide
1
2020
198
0.040
Why?
Bias
1
2020
131
0.040
Why?
Child
2
2022
7113
0.040
Why?
Margins of Excision
1
2019
39
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2023
481
0.040
Why?
Survivors
1
2021
233
0.040
Why?
Phosphoproteins
1
2021
260
0.040
Why?
Asbestosis
2
1998
5
0.040
Why?
Interdisciplinary Communication
1
2020
130
0.040
Why?
Medicare
1
2022
422
0.040
Why?
Living Donors
1
2022
339
0.040
Why?
Sputum
1
2018
35
0.040
Why?
Infection Control
1
2020
120
0.040
Why?
Tissue Donors
1
2022
489
0.040
Why?
Bronchoalveolar Lavage Fluid
1
2018
124
0.040
Why?
Electrocardiography
1
2021
493
0.040
Why?
Tumor Virus Infections
1
1998
81
0.040
Why?
Oligonucleotides, Antisense
1
1998
68
0.040
Why?
Self Report
1
2019
295
0.040
Why?
Regulatory Sequences, Nucleic Acid
1
1998
153
0.040
Why?
Genomics
1
2023
751
0.040
Why?
RNA, Ribosomal, 16S
1
2018
248
0.040
Why?
Heart
1
2021
573
0.040
Why?
Pilot Projects
2
2012
865
0.040
Why?
Liver
1
2022
1204
0.040
Why?
RNA, Antisense
1
1996
15
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2018
164
0.040
Why?
Chemotherapy, Cancer, Regional Perfusion
1
1996
18
0.030
Why?
Sensitivity and Specificity
2
2012
2013
0.030
Why?
Feasibility Studies
2
1996
778
0.030
Why?
Comorbidity
1
2020
947
0.030
Why?
Protein-Tyrosine Kinases
1
2018
307
0.030
Why?
Proto-Oncogene Proteins c-met
1
2018
200
0.030
Why?
Receptor, ErbB-2
1
2018
238
0.030
Why?
B-Lymphocytes
1
2021
738
0.030
Why?
Anniversaries and Special Events
1
2016
14
0.030
Why?
Quality of Life
1
2024
1661
0.030
Why?
Heart Ventricles
1
2021
779
0.030
Why?
Papillomavirus Infections
1
1998
261
0.030
Why?
Chromosome Disorders
1
1995
115
0.030
Why?
Radiation Oncology
1
2017
121
0.030
Why?
Base Sequence
2
1996
2326
0.030
Why?
Genes, Tumor Suppressor
1
1995
159
0.030
Why?
Clinical Trials, Phase II as Topic
1
1995
172
0.030
Why?
National Institutes of Health (U.S.)
1
1995
125
0.030
Why?
Clinical Trials, Phase I as Topic
1
1995
155
0.030
Why?
History, 20th Century
1
2016
310
0.030
Why?
Genetic Predisposition to Disease
1
2023
2331
0.030
Why?
Molecular Sequence Data
2
1996
3026
0.030
Why?
Proto-Oncogene Proteins
1
2018
666
0.030
Why?
Chromosome Aberrations
1
1995
390
0.030
Why?
Genetic Testing
1
2018
537
0.030
Why?
Immunohistochemistry
1
2018
1796
0.030
Why?
DNA Damage
1
1995
371
0.030
Why?
Immunoenzyme Techniques
1
2013
306
0.030
Why?
Fluorescent Antibody Technique
1
2013
323
0.030
Why?
Cricetinae
3
1998
558
0.030
Why?
Genetic Therapy
1
1995
369
0.030
Why?
Pleural Effusion, Malignant
1
2012
16
0.030
Why?
Pleural Effusion
1
2012
47
0.030
Why?
Reactive Oxygen Species
1
1995
487
0.030
Why?
Tumor Necrosis Factor-alpha
1
1996
699
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2013
282
0.030
Why?
Fear
1
2012
79
0.020
Why?
Self Concept
1
2012
132
0.020
Why?
RNA, Small Interfering
1
2013
557
0.020
Why?
Recurrence
1
2014
1140
0.020
Why?
Thoracoscopes
1
2011
2
0.020
Why?
Radiography, Thoracic
1
2013
319
0.020
Why?
Surgical Staplers
1
2011
11
0.020
Why?
Taxoids
1
2011
130
0.020
Why?
Dissection
1
2011
44
0.020
Why?
Computer Graphics
1
2011
100
0.020
Why?
Community-Based Participatory Research
1
2010
36
0.020
Why?
Carboplatin
1
2011
304
0.020
Why?
Motor Skills
1
2011
79
0.020
Why?
Patient Positioning
1
2011
65
0.020
Why?
Kaplan-Meier Estimate
1
2012
858
0.020
Why?
Mediastinum
1
2010
47
0.020
Why?
Affect
1
2012
387
0.020
Why?
Multivariate Analysis
1
2012
986
0.020
Why?
Biopsy, Needle
1
2010
233
0.020
Why?
Down-Regulation
1
2011
519
0.020
Why?
Longitudinal Studies
1
2012
1066
0.020
Why?
Empyema
1
2008
9
0.020
Why?
Depression
1
2012
502
0.020
Why?
Cells, Cultured
1
2013
2879
0.020
Why?
Gene Expression Regulation, Neoplastic
2
2006
1265
0.020
Why?
Insulin-Like Growth Factor I
2
1998
114
0.020
Why?
Plasmids
2
1998
291
0.020
Why?
Carbonic Anhydrase IX
1
2006
11
0.020
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2006
20
0.020
Why?
Regression Analysis
1
2007
590
0.020
Why?
Age Factors
1
2010
1862
0.020
Why?
Tracheal Diseases
1
2005
13
0.020
Why?
Lymphatic Diseases
1
2005
36
0.020
Why?
Polymerase Chain Reaction
2
1998
921
0.020
Why?
Predictive Value of Tests
1
2010
1713
0.020
Why?
Animals
4
1998
27272
0.020
Why?
Reproducibility of Results
1
2010
2750
0.010
Why?
Lymphoma, Non-Hodgkin
1
2005
261
0.010
Why?
Disease Progression
1
2007
1483
0.010
Why?
Gene Expression Regulation, Viral
1
1998
91
0.010
Why?
Virus Replication
1
1998
319
0.010
Why?
HSP70 Heat-Shock Proteins
1
1998
115
0.010
Why?
Oxygenators
1
1996
3
0.010
Why?
Sarcoma, Ewing
1
1996
44
0.010
Why?
Carcinoma, Adenoid Cystic
1
1996
31
0.010
Why?
Cardiac Output
1
1996
156
0.010
Why?
Hyperthermia, Induced
1
1996
73
0.010
Why?
Safety
1
1996
149
0.010
Why?
Cell Transformation, Neoplastic
1
1998
447
0.010
Why?
Cell Division
1
1996
696
0.010
Why?
Sarcoma
1
1996
220
0.010
Why?
Remission Induction
1
1996
738
0.010
Why?
Interferon-gamma
1
1996
451
0.010
Why?
Pulmonary Artery
1
1996
318
0.010
Why?
Blood Pressure
1
1996
898
0.010
Why?
Melanoma
1
1996
466
0.010
Why?
Carcinoma, Renal Cell
1
1996
434
0.010
Why?
Transcription, Genetic
1
1996
1155
0.010
Why?
Rats
1
1996
4039
0.010
Why?
Donington's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (421)
Explore
_
Co-Authors (51)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_